CBD in animals: check the authorisation and product

This page does not attribute efficacy, safety, therapeutic indications or quantities for use to CBD. It only checks the possible regulatory identity of a veterinary medicine.

What the UPD documents

The Union Product Database publishes official, up-to-date information on veterinary medicines authorised in the European Union and the European Economic Area.

To describe a presentation as a veterinary medicine, its record must be identified and its target species, pharmaceutical form, route of administration and authorised indications must be checked.

What this page does not claim

The mere presence of the letters CBD on a label or in a shop is not used here to classify the product as an authorised veterinary medicine.

The page does not classify supplements, feeds or cosmetics, does not apply United States rules to the Italian market, and does not publish clinical claims or administration instructions.

Check the specific product

For a specific product, show the veterinarian or pharmacist the complete pack, label and composition.

Without an exact documentary match, this article does not publish indications, efficacy comparisons or quantities for use.

Sources and document updates

This information is general and does not replace diagnosis, prescription or instructions from a veterinarian. For a medicine, the summary of product characteristics or package leaflet for the specific presentation is authoritative.

• Union Product Database — Veterinary medicines authorised in the European Union (accessed 24/07/2026)

Editorial transparency: sources are provided to allow the documents to be checked. Professional review is only declared after genuine approval by a qualified, identifiable person.